España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Alpha Tau Medical
DRTS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.05
0.14
3.58%
At close: -
$4.10
0.05
1.23%
After Hours: 7:51 PM EDT
Get Report
Comment
Alpha Tau Medical (DRTS) Forecast
News
Earnings
Alpha Tau Medical (DRTS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Alpha Tau Medical (NASDAQ:DRTS) Stock
Alpha Tau Medical Stock (NASDAQ: DRTS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Alpha Tau Announces Upcoming Presentation Of ...
Benzinga Newsdesk
Friday, November 22, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Wednesday, November 20, 2024
Alpha Tau Medical Q3 EPS $(0.10) Beats $(0.13...
Benzinga Newsdesk
Wednesday, October 23, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Monday, October 21, 2024
Alpha Tau Medical Accepted Into FDA's Total P...
Benzinga Newsdesk
Friday, October 11, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Thursday, October 10, 2024
Alpha Tau Treats First Patient with Recurrent...
Benzinga Newsdesk
Friday, September 20, 2024
Alpha Tau Receives FDA Approval To Begin Mult...
Benzinga Newsdesk
Tuesday, August 20, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Thursday, August 15, 2024
Piper Sandler Reiterates Overweight on Alpha ...
Benzinga Newsdesk
On Wednesday August 14, 2024, Alpha Tau Medic...
Benzinga Newsdesk
Wednesday, June 26, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Tuesday, June 25, 2024
Alpha Tau Medical Publishes Pooled Analysis O...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Monday, May 20, 2024
Alpha Tau Medical Q1 EPS $(0.11) Beats $(0.12...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Monday, May 13, 2024
Alpha Tau Treats First Patient With Liver Can...
Benzinga Newsdesk
Monday, May 06, 2024
Alpha Tau Presents Preclinical Data Demonstra...
Benzinga Newsdesk
Tuesday, March 12, 2024
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Friday, March 08, 2024
Piper Sandler Reiterates Overweight on Alpha ...
Benzinga Newsdesk
Wednesday, January 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, December 15, 2023
Expert Ratings for Alpha Tau Medical
Benzinga Insights
Citigroup Initiates Coverage On Alpha Tau Med...
Benzinga Newsdesk
Tuesday, November 28, 2023
Alpha Tau Announces Interim Results From Safe...
Benzinga Newsdesk
Monday, November 20, 2023
Alpha Tau Submits To Japanese PMDA For Pre-Ma...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Friday, November 17, 2023
Analyst Ratings for Alpha Tau Medical
Benzinga Insights
Piper Sandler Maintains Overweight on Alpha T...
Benzinga Newsdesk
Thursday, November 16, 2023
Alpha Tau Medical 9M EPS $(0.31)
Benzinga Newsdesk
Monday, October 30, 2023
Alpha Tau Enters Into Long-Term Lease Of Site...
Benzinga Newsdesk
Wednesday, October 25, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, September 20, 2023
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Thursday, September 14, 2023
Alpha Tau Medical Says A Patient With Advance...
Benzinga Newsdesk
Tuesday, August 29, 2023
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, August 28, 2023
Alpha Tau Medical Announces Q2 2023 Financial...
Happy Mohamed
Friday, August 25, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, August 21, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Thursday, August 17, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Alpha Tau Medical Reports Long-Term Safety An...
Benzinga Newsdesk
Wednesday, August 16, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, July 25, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, May 24, 2023
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Tuesday, May 23, 2023
Recap: Alpha Tau Medical Q1 Earnings
Benzinga Insights
Alpha Tau Medical Q1 EPS $(0.12) Misses $(0.11) Estimate
Happy Mohamed
Thursday, May 18, 2023
HC Wainwright & Co. Reiterates Buy on Alpha T...
Benzinga Newsdesk
Wednesday, May 17, 2023
Alpha Tau Expands Its Alpha DaRT Treatment To Vulvar Cancer In Novel Clinical Trial With Cambridge University
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
